Skip to main content

Advertisement

Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)

Fig. 1

a Blood pressure and pulse rate in amlodipine and azelnidipine groups. Urinary albumin excretion (b) and carotid intima-media thickness (IMT) (c) in amlodipine and azelnidipine groups. Inflammatory factors (d), adipocytokines (e) and soluble adhesion factors (f), in amlodipine and azelnidipine groups. Closed square and bar, amlodipine (n = 19); open triangle and bar, azelnidipine (n = 19). *p < 0.05, # p = 0.055

Back to article page